OTC Markets OTCPK - Delayed Quote • USD
Kali, Inc. (KALY)
At close: May 8 at 9:30 AM EDT
Breakdown
TTM
Total Revenue
105,993.0000
Cost of Revenue
60,175.0000
Gross Profit
45,818.0000
Operating Expense
18,440.0000
Operating Income
27,378.0000
Net Non Operating Interest Income Expense
72.0000
Other Income Expense
355.0000
Pretax Income
27,805.0000
Tax Provision
6,757.0000
Net Income Common Stockholders
20,661.0000
Diluted NI Available to Com Stockholders
20,661.0000
Basic EPS
8.01
Diluted EPS
7.96
Basic Average Shares
2,583.9100
Diluted Average Shares
2,645.8190
Total Operating Income as Reported
27,378.0000
Total Expenses
78,615.0000
Net Income from Continuing & Discontinued Operation
21,048.0000
Normalized Income
20,779.2699
Interest Income
72.0000
Net Interest Income
72.0000
EBIT
28,140.0000
EBITDA
29,060.0000
Reconciled Cost of Revenue
60,175.0000
Reconciled Depreciation
920.0000
Net Income from Continuing Operation Net Minority Interest
21,048.0000
Total Unusual Items Excluding Goodwill
355.0000
Total Unusual Items
355.0000
Normalized EBITDA
28,705.0000
Tax Rate for Calcs
0.0002
Tax Effect of Unusual Items
86.2699
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HMPQ HempAmericana, Inc
0.0000
0.00%
PJET Priority Aviation, Inc.
0.0001
0.00%
EDXC Endexx Corporation
0.0123
-6.82%
AB.PA AB Science S.A.
1.2220
-1.47%
KGKG NuVibe, Inc.
0.0008
0.00%
AYTU Aytu BioPharma, Inc.
3.0900
+0.65%
SNOA Sonoma Pharmaceuticals, Inc.
0.2084
+0.97%
HEMP Hemp, Inc
0.0000
0.00%
PTPI Petros Pharmaceuticals, Inc.
0.4700
-3.73%
AMRX Amneal Pharmaceuticals, Inc.
6.85
+1.48%